Anticoagulation quality and the risk of recurrence of venous thromboembolism

• References

• 1 Christiansen SC, Cannegieter SC, Koster T. et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. J Am Med Assoc 2005; 293: 2352-2361.
• 2 Baglin T. Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet. J Thromb Haemost 2006; 4: 2530-2532.
• 3 Palareti G, Legnani C, Cosmi B. et al. Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. J Thromb Haemost 2005; 3: 955-961.
• 4 Prandoni P, Hutten BA, van Dongen CJ. et al. Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep venous thrombosis. J Thromb Haemost. 2007 Epub ahead of print.
• 5 Gadisseur AP, Christiansen SC, van der Meer FJ. et al. The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study (LETS). J Thromb Haemost 2007; 5: 931-936.
• 6 Italian Federation of Anticoagulation Clinics.. A guide to Oral Anticoagulant Therapy. Haemostasis 1998; 28 (Suppl. 01) 1-46.
• 7 Buller HR, Agnelli G, Hull RD. et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 401S-428S.
• 8 Mariani G, Manotti C, Dettori AG. A computerized regulation of dosage in oral anticoagulant therapy. Res Clin Lab 1990; 20: 119-125.
• 9 Rosendaal FR, Cannegieter SC, van der Meer FJM. et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.
• 10 Poli D, Antonucci E, Cecchi E. et al. Clotting activation after oral anticoagulant therapy discontinuation: a risk factor for recurrent venous thromboembolism. Blood Coagul Fibrinolysis 2004; 15: 221-225.